Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Meng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9987-9024; OpenAlex author ID A5024023342. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Integrated bulk and single-cell transcriptomic analysis reveals inflammatory metabolic programs in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2026.103087↗
  2. Transcriptomic profiling of blood platelets identifies a diagnostic signature for pancreatic cancer. Last author DOI 10.1038/s41416-025-02980-z↗
  3. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer. Co-author DOI 10.18632/oncotarget.10891↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cheng Wang · 1 shared paper, 2026 · strength 0.32
  2. Weiping Ji · 1 shared paper, 2025 · strength 0.27
  3. Gang Jin · 1 shared paper, 2025 · strength 0.27
  4. Hengqiang Zhao · 1 shared paper, 2016 · strength 0.07
  5. Jie Sun · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.